Skip to main content
Professional Technical IVT

NASH

Also written as: NASH — Non-alcoholic steatohepatitis

Non-alcoholic steatohepatitis, an advanced form of fatty liver disease with inflammation.

Full Definition

Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease characterized by hepatic steatosis, inflammation, and hepatocyte injury in the absence of significant alcohol consumption. NASH represents the more severe end of the NAFLD spectrum and can progress to cirrhosis, liver failure, and hepatocellular carcinoma. The condition is strongly associated with metabolic syndrome, diabetes, and obesity, sharing common pathophysiological mechanisms including insulin resistance and chronic inflammation. Diagnosis typically requires liver biopsy, though non-invasive biomarkers and imaging techniques are increasingly utilized.

Usage

Usage note: Always capitalize NASH; distinguish from NAFLD in clinical documentation.

In Context

  • "Liver biopsy confirmed the diagnosis of NASH with stage 2 fibrosis in this diabetic patient." — Pathology report
  • "Weight loss of 7-10% can lead to NASH resolution in a significant proportion of patients." — Treatment guideline

Also known as

non-alcoholic steatohepatitis

Don't confuse with

NAFLD NAFL ASH

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON